Dr. Carladenise Armbrister Edwards Joins Clover Health Board of Directors
27 July 2022 - 6:05AM
Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover
Health” or the “Company”), a physician enablement company committed
to improving health equity for seniors, today announced the
appointment of Carladenise Armbrister Edwards, Ph.D., to the
Company’s Board of Directors.
Dr. Edwards is an accomplished healthcare executive with nearly
three decades of healthcare, nonprofit and government experience.
Currently the Henry Ford Health System’s Executive Vice President
and Chief Strategy Officer, she leads the system’s strategic
planning efforts and partnership ventures, business development and
transformation initiatives, government affairs strategy, as well as
Henry Ford Innovations, the health system’s multi-disciplinary team
responsible for product design and commercialization, technology
transfer, licensing agreements and international programs.
“From strategic roles in government and public service, to
executive leadership positions at some of the nation's leading
academic medical centers, Dr. Edwards brings unmatched experience
and depth of knowledge to Clover,” said Vivek Garipalli, Chief
Executive Officer of Clover. “Her track record of delivering
results for multibillion dollar health and technology organizations
and guiding them to optimal performance will be invaluable as we
continue to strive to make data-driven primary care more equitable
and accessible.”
“The Clover Health team is focused on solving some of
healthcare’s biggest problems,” said Dr. Edwards. “I see Clover
Assistant as a lever for alleviating some of the industry’s
toughest challenges, especially to the benefit of our most
vulnerable populations, and look forward to working closely with
the executive team over the coming months and years to manifest its
fullest potential.”
Prior to Henry Ford, Dr. Edwards was Executive Vice President
and Chief Strategy Officer for Providence St. Joseph Health, a $24
billion Catholic health system comprising 51 hospitals and more
than 800 clinics across seven states. Dr. Edwards’ experience
includes several additional executive leadership roles, including
Chief Administrative Officer for Providence Health & Services’
Population Health division and Chief Strategy Officer for Alameda
Health System.
An expert in the intersection of healthcare and technology, Dr.
Edwards also served as Founding President and CEO of Cal eConnect,
Inc., a nonprofit corporation that governed California’s electronic
Health Information Exchange. She additionally held technology based
leadership roles in Georgia’s Department of Community Health.
Dr. Edwards earned a Ph.D. in Medical Sociology from the
University of Florida, and a master’s degree in Education and
Psychological Services and a bachelor’s degree in Sociology from
the University of Pennsylvania. Dr. Edwards also studied
neuroscience at the University of Leuven in Belgium and gerontology
at the University of California, Los Angeles.
About Clover Health:Clover Health (Nasdaq:
CLOV) is a physician enablement company focused on seniors who have
historically lacked access to affordable, high-quality healthcare.
Our strategy is underpinned by our proprietary software platform,
Clover Assistant, which is designed to aggregate patient data from
across the health ecosystem to support clinical decision-making and
improve health outcomes. We operate two distinct lines of business:
Insurance and Non-Insurance. Through our Insurance line of
business, we provide PPO and HMO plans to Medicare Advantage
members in several states. Our Non-Insurance line of business
offers a variety of programs aimed at reducing expenditures and
enhancing the quality of care for patients enrolled in
fee-for-service Medicare. Clover’s corporate headquarters are in
Franklin, Tenn.
Visit: www.cloverhealth.com
Press Contact:Andrew
Still-Baxterpress@cloverhealth.com
Investor Relations Contact:Ryan
Schmidtinvestors@cloverhealth.com
Clover Health Investments (NASDAQ:CLOV)
Historical Stock Chart
From Apr 2024 to May 2024
Clover Health Investments (NASDAQ:CLOV)
Historical Stock Chart
From May 2023 to May 2024